Analyzing Systematic Financial Management LP's Q3 2022 vs. Q4 2022 13F Holdings
Ava Hoppe | 28 April, 2023
The 13F filings of hedge funds, institutional investors, and investment advisers are crucial to understanding their investment strategies. Systematic Financial Management LP, a global asset management firm, recently released its Q3 2022 vs. Q4 2022 13F holdings, and the results are quite interesting.
FCNCA, MGY, and CCRN are among the top holdings of the firm. All three have seen a decrease in the number of shares held, with FCNCA experiencing the largest decrease of 7.2%. In contrast, the value of the shares held by MGY has increased by 16.2%, while CCRN's value has decreased by 15.1%.
EME, NWE, and KBR are other holdings of Systematic Financial Management LP that have seen an increase in the value of the shares held. EME's value has increased by 24%, while NWE and KBR's value has increased by 18.3% and 17.1%, respectively.
Other holdings of the firm, such as WAFD, WBS, and ICFI, have remained relatively stable, with WAFD and WBS' value increasing by 15.2% and 4.2%, respectively, while ICFI's value has decreased by 10.8%.
In contrast, holdings such as PIPR, EHC, and PRGO have seen a significant increase in the value of shares held. PIPR's value has increased by 25.8%, EHC's by 30.8%, and PRGO's by a massive 140.6%.
The holdings of Systematic Financial Management LP that have seen a decrease in the value of the shares held include TSTR, REX, and SASR. TSTR's value has decreased by 1.2%, while REX's value has increased by 5.7%. Meanwhile, SASR has seen a decrease of 3.5%.
Overall, it's clear that Systematic Financial Management LP has made some significant changes to its portfolio. The firm has reduced its holdings in some positions while increasing the value of shares held in others. Nevertheless, it is critical to note that these changes may not necessarily reflect the firm's investment strategy and may be subject to market fluctuations and other factors.
In conclusion, Systematic Financial Management LP's Q3 2022 vs. Q4 2022 13F holdings provide insight into its investment strategy, and there is a lot to glean from this report. It highlights the importance of keeping track of these periodic filings and analyzing how investment firms are managing their portfolios.
Other Posts
- Revolutionizing Therapeutics: Flashpoint Therapeutics Receives $10M Seed Financing from Beta Lab
- Comparing Q3 and Q4 2022: Boothbay Fund Management, LLC's Top Holdings
- Cetera Advisor Networks' Q4 2022 13F Filings Show Changes in Key Holdings
- Potrero Capital Research LLC's Q3 2022 vs. Q4 2022 13F Holdings: Changes in Top Positions and New Holdings
- Diversified Investment Strategies, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Silverleafe Capital Partners, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- The Rise and Fall of Scharf Investments LLC Q4 2022 vs. Q1 2023
- McGuire Investment Group, LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- 13F Holdings Review of Guyasuta Investment Advisors Inc Q3 2022 vs. Q4 2022
- GRAM Launches New Americas Buyout Fund to Invest in the Hispanic Ecosystem